{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:11:21Z","timestamp":1789783881397,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.yebeh.2016.09.030","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:34:12Z","timestamp":1476232452000},"page":"110-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"PA","title":["Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus"],"prefix":"10.1016","volume":"64","author":[{"given":"Francesco","family":"Brigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bragazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2016.09.030_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2014 report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00004691-199512040-00003","article-title":"Epidemiology of status epilepticus","volume":"12","author":"DeLorenzo","year":"1995","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0015","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1756285608100460","article-title":"New treatment options in status epilepticus: a critical review on intravenous levetiracetam","volume":"2","author":"Trinka","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eplepsyres.2015.04.013","article-title":"Management of generalised convulsive status epilepticus (SE): a prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam\u2014pilot study","volume":"114","author":"Mundlamuri","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0035","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jocn.2014.12.013","article-title":"Levetiracetam versus phenytoin in management of status epilepticus","volume":"22","author":"Chakravarthi","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0050","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/0883073807306248","article-title":"Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial","volume":"22","author":"Mehta","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jocn.2008.06.007","article-title":"Intravenous sodium valproate in mainland China for the treatment of diazepam refractory convulsive status epilepticus","volume":"16","author":"Chen","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0065","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","article-title":"Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial","volume":"16","author":"Malamiri","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1468-1331.2011.03606.x","article-title":"IV valproate in generalized convulsive status epilepticus: a systematic review","volume":"19","author":"Brigo","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Trinka","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","article-title":"It's time to revise the definition of status epilepticus","volume":"40","author":"Lowenstein","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0085","series-title":"Handbook for systematic reviews of interventions version 5.1.0 (updated March 2011)","year":"2011"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0095","first-page":"1","article-title":"International Stroke Trial Collaborative Group","volume":"9","author":"Glenny","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0100","series-title":"Report of the indirect comparisons working group to the pharmaceutical benefits advisory committee: assessing indirect comparisons","author":"ICWG","year":"2009"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis or randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.wnf.0000159956.87511.67","article-title":"Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy","volume":"28","author":"Otoul","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1684\/epd.2013.0601","article-title":"A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus","volume":"15","author":"Brigo","year":"2013","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.seizure.2013.03.016","article-title":"Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine","volume":"22","author":"Zaccara","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40263-015-0271-x","article-title":"A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus","volume":"29","author":"Brigo","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/1082-989X.8.3.243","article-title":"How meta-analysis increases statistical power","volume":"8","author":"Cohn","year":"2003","journal-title":"Psychol Methods"},{"key":"10.1016\/j.yebeh.2016.09.030_bb0140","article-title":"Anticonvulsant therapy for status epilepticus","volume":"9","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 8","key":"10.1016\/j.yebeh.2016.09.030_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03237.x","article-title":"Established status epilepticus treatment trial (ESETT)","volume":"52","author":"Cock","year":"2011","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2016.09.030_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016302360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016302360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T05:22:27Z","timestamp":1657689747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505016302360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":30,"alternative-id":["S1525505016302360"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.09.030","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}